Advisor Group’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Advisor Group’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$78K	Sell	2,798 -247	-8%	-$6.5K	﹤0.01%	3119
2019 Q3	$74K	Sell	3,045 -967	-24%	-$24K	﹤0.01%	3115
2019 Q2	$103K	Buy	4,012 +1,498	+60%	+$37.5K	﹤0.01%	2843
2019 Q1	$65K	Buy	+2,514	New	+$64.1K	﹤0.01%	3201

Other funds holding IEIH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisor Group's IEIH Position: Q4 2019 in Review

Advisor Group reduced its iShares Evolved U.S. Innovative Healthcare ETF (IEIH) stake by 8.1% in Q4 2019, selling an estimated $6.5K and leaving 2,798 shares worth $78K. The position accounts for ﹤0.01% of the portfolio, ranked #3119.

Advisor Group first reported a position in IEIH in Q1 2019 and has held it in 4 quarters since. The position peaked at $103K in Q2 2019. 7 funds tracked by Wall St. Rank hold IEIH as of Q4 2019.

Advisor Group held 2,798 shares of iShares Evolved U.S. Innovative Healthcare ETF worth $78K as of Q4 2019.
Advisor Group sold 247 iShares Evolved U.S. Innovative Healthcare ETF shares in Q4 2019, an estimated $6.5K.
iShares Evolved U.S. Innovative Healthcare ETF made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3119 holding.
Advisor Group first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q1 2019 and has held it in 4 quarters since.
Advisor Group's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $103K in Q2 2019.
7 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.